...at least three products could threaten that position. FDA approved competing product Jeuveau prabotulinumtoxinA from Evolus Inc....
...Companies and Institutions Mentioned AbbVie Inc. (NYSE:ABBV), North Chicago, Ill. Allergan plc (NYSE:AGN), Dublin, Ireland Evolus Inc....

...Doptelet is an oral CD110 agonist. Dova climbed $0.84 to $9.36 Friday. Nuceiva prabotulinumtoxinA from Evolus Inc....
...under age 65 when the severity of the facial lines has an important psychological impact. Evolus...
...an injectable 900 kiloDalton (kDa) botulinum toxin type A complex, as Jeuveau in the U.S. Evolus...

...Friday. At least seven companies are awaiting a CHMP opinion or EC action this quarter: Evolus Inc....

...epithelioid sarcoma Submit NDA 2Q19 Evofem Biosciences Inc. (NASDAQ:EVFM) Amphora Prevent pregnancy Resubmit NDA 2Q19 Evolus Inc....

...testosterone undecanoate for testosterone replacement therapy in adult males for primary hypogonadism and hypogonadotropic hypogonadism Evolus...

...of major depressive disorder (MDD) in patients with an inadequate response to antidepressants 1/31/19 Standard Evolus Inc....

...Inc. (NASDAQ:EVOK) Gimoti (EVK-001) Acute and recurrent diabetic gastroparesis in adult women PDUFA date 4/1/19 Evolus Inc....

...regulatory and quality at Sucampo Pharmaceuticals Inc., which Mallinckrodt plc (NYSE:MNK) acquired. Jaime De Leon Collegium Pharmaceutical Inc. Evolus Inc. EyePoint...

...$30.5 $141.6 $247.1 75% Korea Arlico Pharm Co. Ltd. (KOSDAQ:260660) 2/12/18 $26.0 $97.8 $115.4 18% Evolus Inc....

...Herzuma trastuzumab (CT-P6), a biosimilar of Herceptin, and Truxima rituximab (CT-P10), a biosimilar of Rituxan Evolus Inc....